Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 15.09.2025 2 BMJ 1 Clin Infect Dis 1 Infect Immun 2 J Virol 3 JAMA 1 N Engl J Med 1 Nat Med 2 Pediatr Infect Dis J 1 PLoS Med 3 PLoS One 1 Science 19 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. IACOBUCCI G
   Malhotra: GMC is urged to act after doctor links covid vaccines to cancer in royal family.
   BMJ. 2025;390:r1896.
   PubMed        
   
   
2. TANNE JH
   RFK Jr is grilled over vaccines and CDC chaos at fiery US Senate hearing.
   BMJ. 2025;390:r1882.
   PubMed        
   
   

   
   Clin Infect Dis

3. SHETTY AN, Hennessy D, Kattan GS, Ojaimi S, et al
   Transient increased risk of shingles post Shingrix vaccination: Self-controlled case series analysis.
   Clin Infect Dis. 2025 Sep 9:ciaf473. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Immun

4. LIU T, Zhao H, Wu Q, Wei Y, et al
   Evaluation of Mycoplasma mycoides subsp. mycoides antigens capable of stimulating host IRG-47 release identifies Mmm604, Mmm605, and Mmm606 as potential subunit vaccine antigens.
   Infect Immun. 2025 Sep 9:e0018625. doi: 10.1128/iai.00186.
   PubMed         Abstract available
   
   

   
   J Virol

5. CAO M, Li Y, Song X, Lu Z, et al
   Broad-spectrum vaccines against various and evolving viruses: from antigen design to nanoparticle delivery.
   J Virol. 2025 Sep 12:e0099725. doi: 10.1128/jvi.00997.
   PubMed         Abstract available
   
   
6. FAN W, Zeng X, Chen Y, Yu Q, et al
   A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens.
   J Virol. 2025 Sep 11:e0114925. doi: 10.1128/jvi.01149.
   PubMed         Abstract available
   
   

   
   JAMA

7. LIU Z, Zhang L, Jiang M
   Influenza and COVID-19 Multicomponent Vaccine in Adults.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
   PubMed        
   
   
8. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
   Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
   PubMed        
   
   
9. SCHNEIDER L
   New Vaccination Guidance for Adults With Heart Disease.
   JAMA. 2025 Sep 12. doi: 10.1001/jama.2025.13873.
   PubMed        
   
   

   
   N Engl J Med

10. NSANZIMANA S, Remera E, Nkeshimana M, Westergaard RP, et al
    Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.
    N Engl J Med. 2025;393:983-993.
    PubMed         Abstract available
    
    

    
    Nat Med

11. NYOMBAYIRE J, Ingabire R, Mazzei A, Sharkey T, et al
    Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.
    Nat Med. 2025 Sep 8. doi: 10.1038/s41591-025-03932.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

12. LAZARO-MARTIN B, Tarancon-Diez L, Camino Lopez M, Alonso R, et al
    A Prospective Cohort Study of Hepatitis B Virus Vaccination in Pediatric Heart Transplant Recipients: Cellular and Humoral Immune Responses and the Role of Innate Immunity.
    Pediatr Infect Dis J. 2025 Sep 11. doi: 10.1097/INF.0000000000004958.
    PubMed         Abstract available
    
    
13. NOBLE C, Gualtieri R, Mattiello V, Cimasoni L, et al
    Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease: A Retrospective Single-center Study.
    Pediatr Infect Dis J. 2025 Aug 29. doi: 10.1097/INF.0000000000004947.
    PubMed         Abstract available
    
    

    
    PLoS Med

14. MANDOLO J, Mulira L, Moyo M, Mvula M, et al
    Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study.
    PLoS Med. 2025;22:e1004734.
    PubMed         Abstract available
    
    

    
    PLoS One

15. PHIRI MM, Osman R, Weldegebriel S, Sabola S, et al
    Exploration of the social determinants of diarrhoea, rotavirus vaccine uptake, and vaccine 'fatigue' in Ethiopia, Kenya, and Malawi.
    PLoS One. 2025;20:e0319691.
    PubMed         Abstract available
    
    
16. DELL'ANTONIO CSDS, Bierrenbach AL
    Epidemiological patterns of SARS-CoV-2 reinfections in Espirito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.
    PLoS One. 2025;20:e0331771.
    PubMed         Abstract available
    
    
17. ENDEHABTU BF, Alemu K, Mengiste SA, Zelalem M, et al
    Spatial disparities in zero-dose vaccination coverage for children aged 12-23 months in Ethiopia: A geographically weighted regression analysis.
    PLoS One. 2025;20:e0332162.
    PubMed         Abstract available
    
    

    
    Science

18. COHEN J
    Florida plan to nix vaccine mandates raises alarm.
    Science. 2025;389:1075-1076.
    PubMed         Abstract available
    
    

    
    Vaccine

19. GARCIA-FOGEDA I, Abrams S, Vanhee S, Salloum M, et al
    Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo.
    Vaccine. 2025;64:127707.
    PubMed         Abstract available
    
    
20. MOHAMED Y, Danchin M, Boyd L, Nightingale C, et al
    A scoping review of multicomponent interventions to improve uptake of routine childhood vaccines in low- and middle-income countries.
    Vaccine. 2025;64:127727.
    PubMed         Abstract available
    
    
21. TIBAVIJA SS, Almario MP, Jaramillo V, Rivera J, et al
    Validation and evaluation of the rapid fluorescent focus inhibition test (RFFIT) for the quantification of neutralizing antibodies as an indirect measure of rabies vaccine relative potency: An alternative to the NIH test.
    Vaccine. 2025;64:127724.
    PubMed         Abstract available
    
    
22. ROY DN, Rashid M, Aktar A, Parvin MS, et al
    Potential predictors of COVID-19 booster vaccine confidence among adult people: a cross-sectional analysis amid the Omicron surge in Southern Bangladesh.
    Vaccine. 2025;64:127693.
    PubMed         Abstract available
    
    
23. HUANG YT, Tsou TP, Kuo SH, Huang YT, et al
    Assessment of influenza vaccine effectiveness among the elderly in Taiwan using population-based registry data for the 2023-2024 season.
    Vaccine. 2025;64:127690.
    PubMed         Abstract available
    
    
24. BOGA DJ, Robinson M, Tirupathi M, Juste RS, et al
    Latent class and time-to-event analyses of social determinants of health and COVID-19 vaccine uptake among Black women living with HIV.
    Vaccine. 2025;64:127649.
    PubMed         Abstract available
    
    
25. MUES KE, Zhou CK, Gerber JE, van Hunsel F, et al
    A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic.
    Vaccine. 2025;64:127691.
    PubMed         Abstract available
    
    
26. HAMAD SAIED M, El Bied N, Khoury L, Vastert SJ, et al
    Safety, immunogenicity and efficacy of the Shingrix vaccine in immunocompromised varicella zoster virus naive pediatric patients.
    Vaccine. 2025;64:127708.
    PubMed         Abstract available
    
    
27. KISHINO H, Inoue S, Matsuoka O, Yagi M, et al
    Corrigendum to "A phase 3 randomized trial (STRIDE-9) to evaluate the safety, tolerability, and immunogenicity of V116, a population-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-naive Japanese adults >/=65 years of age" [Vaccine 62
    Vaccine. 2025;64:127688.
    PubMed        
    
    
28. TINESSIA A, Sabahelzain MM, King C, Khalatbari-Soltani S, et al
    Systematic review of pro-equity strategies to improve vaccination among priority populations.
    Vaccine. 2025;64:127694.
    PubMed         Abstract available
    
    
29. ZHAO Y, Zhao Z, Cheng C, Tian M, et al
    A bivalent SARS-CoV-2 subunit vaccine for cats neutralizes both the original ancestral strain and BA.1 Pseudovirus carrying the 453F and 501 T mutation.
    Vaccine. 2025;64:127685.
    PubMed         Abstract available
    
    
30. WANG Y, Ni Y, Leung CMC, Ning K, et al
    Longitudinal patterns and predictors of COVID-19 vaccine confidence from pre-vaccine rollout to mass vaccination: A population-based cohort study.
    Vaccine. 2025;64:127736.
    PubMed         Abstract available
    
    
31. BALMUTH A, Brennan T, Ashebir S, D'Ambrosio L, et al
    Examining the contributions of demographic variables to vaccination uptake among the U.S. aged 50.
    Vaccine. 2025;64:127711.
    PubMed         Abstract available
    
    
32. CHAN YL, Chao YP, Li TL, Liao KW, et al
    Chitosan-based Oral DNA vaccine elicits mucosal immunity and reduces Helicobacter pylori colonization in mice.
    Vaccine. 2025;64:127692.
    PubMed         Abstract available
    
    
33. BARBERIA LG, Seelaender ICR, Carvalho RJ, de Moraes JC, et al
    Caregivers' attitudes toward school-based vaccination programs: A comparison of COVID-19, HPV, influenza, and dengue vaccines in Brazil.
    Vaccine. 2025;64:127709.
    PubMed         Abstract available
    
    
34. DIEMERT DJ, Graciaa DS, Zhang B, Rouphael NG, et al
    Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.
    Vaccine. 2025;64:127718.
    PubMed         Abstract available
    
    
35. ARSUFFI S, Rossi L, Colombo FR, Inverardi M, et al
    Herpes zoster reactivation in a cohort of people living with HIV vaccinated with recombinant vaccine.
    Vaccine. 2025;64:127723.
    PubMed         Abstract available
    
    
36. SANFTENBERG L, Kraeker L, Walter F, Tsiligianni I, et al
    Associations between common mental disorders and vaccination readiness against seasonal influenza and Covid-19 of chronically ill adult patients in primary care - a systematic review.
    Vaccine. 2025;64:127682.
    PubMed         Abstract available
    
    
37. ASIM M, Jessani S, Saleem S, Yasmeen H, et al
    Myths, mandates, and decision-making: A qualitative exploration of COVID-19 vaccine hesitancy among pregnant and postpartum women in Pakistan.
    Vaccine. 2025 Sep 9:127722. doi: 10.1016/j.vaccine.2025.127722.
    PubMed         Abstract available
    
    

    
    Virology

38. BABA S, Koyama T, Komatsu D, Uchino T, et al
    Development of an effective DNA vaccine against ayu atypical cellular gill disease using draft genome information of the causative agent, Plecoglossus altivelis poxvirus.
    Virology. 2025;612:110671.
    PubMed         Abstract available
    
    
39. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.